These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26812877)

  • 1. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of cytokine production profiles as a therapeutic approach for immunologic pregnancy loss.
    Raghupathy R
    Indian J Biochem Biophys; 2008 Aug; 45(4):229-36. PubMed ID: 18788472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dydrogesterone in recurrent (habitual) abortion.
    Gruber CJ; Huber JC
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Progesterone, Dydrogesterone and Estrogen on the Production of Th1/Th2/Th17 Cytokines by Lymphocytes from Women with Recurrent Spontaneous Miscarriage.
    AbdulHussain G; Azizieh F; Makhseed M; Raghupathy R
    J Reprod Immunol; 2020 Aug; 140():103132. PubMed ID: 32380371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
    Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
    Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone.
    Raghupathy R; Al-Azemi M
    Am J Reprod Immunol; 2015 Nov; 74(5):419-26. PubMed ID: 26250154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal support: progestogens for pregnancy protection.
    Daya S
    Maturitas; 2009 Dec; 65 Suppl 1():S29-34. PubMed ID: 19913373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile.
    Blois SM; Joachim R; Kandil J; Margni R; Tometten M; Klapp BF; Arck PC
    J Immunol; 2004 May; 172(10):5893-9. PubMed ID: 15128769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.
    Sammour MB; el-Kabarity H; Fawzy MM; Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):439-40. PubMed ID: 16236493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchorionic hemorrhage treatment with dydrogesterone.
    Pelinescu-Onciul D
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():77-81. PubMed ID: 17943544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.